Microbial consortia and IP in Europe
Protecting new and inventive innovations in this increasingly crowded area is essential, explains Ine Vanderleyden of Mewburn Ellis.
- Neurim, Flynn discover that time is not on their side 26-05-2022
- When alliances fail, is arbitration the answer? 24-02-2022
- NHS v Servier: unlawful means tort claim fails, but the long-running saga continues 17-08-2021
- UK experimental use exemptions: Part 4—the SPC manufacturing and stockpiling waiver 10-08-2021
- UK experimental use exemptions: part 1—the original 15-07-2021
Latest europe news
Oxford University startup ordered to pay royalties
05-01-2023
‘Rare’ case included ‘campaigning element’ says judge | Ex-student sought clarification on royalties from university | 651-paragraph ruling required Oxford Uni to justify its IP policies.
Amgen seals $28m deal for biotech
13-12-2022
